MyFinsight
Home
Blog
About
Contact
Back
Income Statement
Milestone Pharmaceuticals Inc. (MIST)
Milestone Pharmaceuticals Inc. (MIST)
source: myfinsight.com
Download
Download image
Net loss and
comprehensive loss
-$26,066K
(-25.55%↓ Y/Y)
Interest income
$1,732K
(148.49%↑ Y/Y)
Loss from operations
-$23,663K
(-15.30%↓ Y/Y)
Interest expense
$4,135K
(342.25%↑ Y/Y)
Total revenues
$238K
Total operating
expenses
$23,901K
Commercial
$15,812K
(52.36%↑ Y/Y)
General and
administrative
$4,824K
(-6.64%↓ Y/Y)
Research and
development, net of tax...
$3,251K
(-34.69%↓ Y/Y)
Cost of product sales
$14K
Back